About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 614081, 8 pages
http://dx.doi.org/10.1155/2013/614081
Clinical Study

Alkaline Phosphatase: The Next Independent Predictor of the Poor 90-Day Outcome in Alcoholic Hepatitis

Department of Gastroenterology with Endoscopy Unit, Medical University of Lublin, 8 Jaczewski Street, 20-954 Lublin, Poland

Received 14 April 2013; Revised 30 July 2013; Accepted 13 August 2013

Academic Editor: Atsushi Sakuraba

Copyright © 2013 Beata Kasztelan-Szczerbinska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organisation, Global Status Raport on Alcohol and Health 2011, World Health Organisation, Geneva, Switzerland, 2011.
  2. A. J. McCullough, R. S. O'Shea, and S. Dasarathy, “Diagnosis and management of alcoholic liver disease,” Journal of Digestive Diseases, vol. 12, no. 4, pp. 257–262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. R. S. O'Shea, S. Dasarathy, and A. J. McCullough, “Alcoholic liver disease,” Hepatology, vol. 51, no. 1, pp. 307–328, 2010. View at Publisher · View at Google Scholar
  4. M. Amini and B. A. Runyon, “Alcoholic hepatitis 2010: a clinician's guide to diagnosis and therapy,” World Journal of Gastroenterology, vol. 16, no. 39, pp. 4905–4912, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. E. H. Forrest, C. D. J. Evans, S. Stewart et al., “Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score,” Gut, vol. 54, no. 8, pp. 1174–1179, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Dunn, L. H. Jamil, L. S. Brown et al., “MELD accurately predicts mortality in patients with alcoholic hepatitis,” Hepatology, vol. 41, no. 2, pp. 353–358, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. E. H. Forrest, A. J. Morris, S. Stewart et al., “The Glasgow alcoholic hepatitis score identifies patients who may benefit from corticosteroids,” Gut, vol. 56, no. 12, pp. 1743–1746, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Srikureja, N. L. Kyulo, B. A. Runyon, and K. Q. Hu, “MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis,” Journal of Hepatology, vol. 42, no. 5, pp. 700–706, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. B. E. Vaa, S. K. Asrani, W. Dunn, P. S. Kamath, and V. H. Shah, “Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis,” Mayo Clinic Proceedings, vol. 86, no. 1, pp. 37–42, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Dominguez, D. Rincón, J. G. Abraldes et al., “A new scoring system for prognostic stratification of patients with alcoholic hepatitis,” American Journal of Gastroenterology, vol. 103, no. 11, pp. 2747–2756, 2008. View at Publisher · View at Google Scholar
  11. T. F. Babor, J. C. Higgins-Biddle, J. B. Saunders, and M. G. Monteiro, AUDIT the Alcohol Use Disorders: Identification Test Guidelines for Use in Primary Care, World Health Organisation, Geneva, Switzerland, 2nd edition, 2001.
  12. G. Basra, S. Basra, and S. Parupudi, “Symptoms and signs of acute alcoholic hepatitis,” World Journal of Hepatology, vol. 3, no. 5, pp. 118–120, 2011.
  13. R. Hamid and E. H. Forrest, “Is histology required for the diagnosis of alcoholic hepatitis: a review of published randomized controlled trials,” Gut, vol. 60, article A233, 2011. View at Publisher · View at Google Scholar
  14. European Association for the Study of the Liver, “EASL Clinical Practice Guidelines: management of cholestatic liver diseases,” Journal of Hepatology, vol. 51, no. 2, pp. 237–267, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. H. Tan, S. Virmani, and P. Martin, “Controversies in the management of alcoholic liver disease,” Mount Sinai Journal of Medicine, vol. 76, no. 5, pp. 484–498, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Altamirano, C. Fagundes, M. Dominguez et al., “Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis,” Clinical Gastroenterology and Hepatology, vol. 10, no. 1, pp. 65–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. P. Cervoni, T. Thévenot, D. Weil et al., “C-reactive protein predicts short-term mortality in patients with cirrhosis,” Journal of Hepatology, vol. 56, no. 6, pp. 1299–1304, 2012. View at Publisher · View at Google Scholar
  18. H. Garg, A. Kumar, V. Garg, P. Sharma, B. C. Sharma, and S. K. Sarin, “Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure,” Digestive and Liver Disease, vol. 44, no. 2, pp. 166–171, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. G. V. Papatheodoridis, E. Cholongitas, E. Dimitriadou, G. Touloumi, V. Sevastianos, and A. J. Archimandritis, “MELD versus Child-Pugh and creatinine-modified Child-Pugh score for predicting survival in patients with decompensated cirrhosis,” World Journal of Gastroenterology, vol. 11, no. 20, pp. 3099–3104, 2005. View at Scopus
  20. M. O. Martinez, H. Sayles, R. Vivekanandan, S. D'Souza, and M. C. Florescu, “Hepatorenal syndrome: are we missing some prognostic factors?” Digestive Diseases and Sciences, vol. 57, no. 1, pp. 210–214, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. T. I. Huo, J. C. Wu, H. C. Lin et al., “Evaluation of the increase in model for end-stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score,” Journal of Hepatology, vol. 42, no. 6, pp. 826–832, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Spahr, L. Rubbia-Brandt, M. Genevay, A. Hadengue, and E. Giostra, “Early liver biopsy, intraparenchymal cholestasis, and prognosis in patients with alcoholic steatohepatitis,” BMC Gastroenterology, vol. 11, article 115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. K. Singal, P. S. Kamath, G. J. Gores, and V. H. Shah, “Alcoholic hepatitis: current challenges and future directions,” Clinical Gastroenterology and Hepatology, 2013. View at Publisher · View at Google Scholar
  24. R. Bettini and M. Gorini, “Effectiveness of ursodeoxycholic acid associated silymarin in the treatment of chronic athrylic hepatopathy,” Clinica Terapeutica, vol. 153, no. 5, pp. 305–307, 2002. View at Scopus
  25. G. Pelletier, D. Roulot, T. Davion et al., “A randomized controlled trial of ursodeoxycholic acid in patients with alcohol-induced cirrhosis and jaundice,” Hepatology, vol. 37, no. 4, pp. 887–892, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. F. Salerno, M. Merli, M. Cazzaniga et al., “MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt,” Journal of Hepatology, vol. 36, no. 4, pp. 494–500, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Wiesner, E. Edwards, R. Freeman et al., “Model for end-stage liver disease (MELD) and allocation of donor livers,” Gastroenterology, vol. 124, no. 1, pp. 91–96, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. B. Angermayr, A. Luca, F. König et al., “Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score,” European Journal of Clinical Investigation, vol. 39, no. 1, pp. 65–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. K. A. Attia, K. C. Ackoundou-N'guessan, A. T. N'dri-yoman et al., “Child-Pugh-Turcott versus Meld score for predicting survival in a retrospective cohort of black African cirrhotic patients,” World Journal of Gastroenterology, vol. 14, no. 2, pp. 286–291, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Gotthardt, K. H. Weiss, M. Baumgärtner et al., “Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation,” BMC Gastroenterology, vol. 9, article 72, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. X. H. Lv, H. B. Liu, Y. Wang, B. Y. Wang, M. Song, and M. J. Sun, “Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis,” Journal of Gastroenterology and Hepatology, vol. 24, no. 9, pp. 1547–1553, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. W. Biggins, H. J. Rodriguez, P. Bacchetti, N. M. Bass, J. P. Roberts, and N. A. Terrault, “Serum sodium predicts mortality in patients listed for liver transplantation,” Hepatology, vol. 41, no. 1, pp. 32–39, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. W. R. Kim, S. W. Biggins, W. K. Kremers et al., “Hyponatremia and mortality among patients on the liver-transplant waiting list,” New England Journal of Medicine, vol. 359, no. 10, pp. 1018–1026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. N. Yamashiki, Y. Sugawara, S. Tamura et al., “Model for end-stage liver disease and model for end-stage liver disease-na scores predict both before-listing and wait-list mortality,” Transplantation Proceedings, vol. 44, no. 2, pp. 389–392, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Angermayr, M. Cejna, F. Karnel et al., “Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt,” Gut, vol. 52, no. 6, pp. 879–885, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. T. D. Sandahl, P. Jepsen, P. Ott, and H. Vilstrup, “Validation of prognostic scores for clinical use in patients with alcoholic hepatitis,” Scandinavian Journal of Gastroenterology, vol. 46, no. 9, pp. 1127–1132, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Sheth, M. Riggs, and T. Patel, “Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis,” BMC Gastroenterology, vol. 2, article 2, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. A. S. Soultati, S. P. Dourakis, A. Alexopoulou, M. Deutsch, L. Vasilieva, and A. J. Archimandritis, “Predicting utility of a model for end stage liver disease in alcoholic liver disease,” World Journal of Gastroenterology, vol. 12, no. 25, pp. 4020–4025, 2006. View at Scopus
  39. M. Somsouk, R. Kornfield, E. Vittinghoff, J. M. Inadomi, and S. W. Biggins, “Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk,” Liver Transplantation, vol. 17, no. 2, pp. 129–136, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Akriviadis, R. Botla, W. Briggs, S. Han, T. Reynolds, and O. Shakil, “Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial,” Gastroenterology, vol. 119, no. 6, pp. 1637–1648, 2000. View at Scopus